Cardinal Sees No Rx Distribution Disruptions After April 1 Fee-For-Service Deadline
This article was originally published in The Pink Sheet Daily
Executive Summary
Most drug manufacturers have agreed in principle to fee-for-service distribution contracts, Cardinal CEO Walter says. Negotiations are now focused on price, not the methodology for paying wholesalers, he says.